Early Rule-out of Acute Myocardial Infarction with Copeptin - Professor Martin Möckel Interview скачать в хорошем качестве

Early Rule-out of Acute Myocardial Infarction with Copeptin - Professor Martin Möckel Interview

Interview with Professor Martin Möckel, Professor of Cardiology, and Chief, Division of Emergency Medicine, Charite Mitte, Berlin Fast. Effective. Safe. Acute myocardial infarction (AMI) may safely be ruled out by testing a single blood sample at patient presentation. In a recently-completed intervention study, using a Copeptin-based diagnostic algorithm enabled immediate discharge of 2/3 of patients with suspected acute coronary syndrome (ACS) from the emergency department. At 30 days, patients managed using Copeptin had 100% survival and a comparably low major cardiovascular event rate (MACE) to that in patients undergoing conventional multiple laboratory testing and hours-long observation. Based on these results, the Thermo Scientific™ B•R•A•H•M•S™ Copeptin biomarker assays improve patient care and clinical resource allocation - without compromising safety.